Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy.
Saved in:
| Title: | Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy. |
|---|---|
| Authors: | Ganan-Gomez I; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yang H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ma F; Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA, USA.; Division of Rheumatology, Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Thongon N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Marchica V; Department of Medicine and Surgery, University of Parma, Parma, Italy., Richard-Carpentier G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chien K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Manyam G; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang F; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Alfonso A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chen S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Class C; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ingram JP; AbbVie Oncology Discovery, Chicago, IL, USA., Ogoti Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rose A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lockyer P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cambo B; Department of Medicine and Surgery, University of Parma, Parma, Italy., Muftuoglu M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Schneider S; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Adema V; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McLellan M; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA., Garza J; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA., Marchesini M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori', Meldola, Italy., Giuliani N; Department of Medicine and Surgery, University of Parma, Parma, Italy., Pellegrini M; Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA, USA., Wang J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Walker J; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA., Li Z; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Leverson JD; AbbVie Oncology Discovery, Chicago, IL, USA., Bueso-Ramos C; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Andreeff M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Clise-Dwyer K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Colla S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. scolla@mdanderson.org. |
| Source: | Nature medicine [Nat Med] 2022 May; Vol. 28 (5), pp. 1097. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
